Stefan Ciurea, MD, Hematology, Irvine, CA, UCI Medical Center

StefanOctavianCiureaMD

Hematology Irvine, CA

Physician

Dr. Ciurea is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ciurea's full profile

Already have an account?

Summary

  • Stefan O. Ciurea, MD, directs the Hematopoietic Stem Cell Transplant and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center. Before joining UCI, he served for more than a decade on the faculty of MD Anderson’s Department of Stem Cell Transplantation and Cellular Therapy, where he pioneered the use of haploidentical donors for transplantation and a promising new approach using natural killer (NK) cells to decrease relapse after transplant.
    Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania, followed by an internal medicine residency at UPMC Pinnacle Harrisburg in Pennsylvania. He completed a hematology-oncology fellowship at the Chicago College of Medicine, and a fellowship in stem-cell transplantation and cellular therapy at the MD Anderson Cancer Center in Houston.
    A professor of hematology/oncology at the UCI School of Medicine, he is the author of more than 150 peer-reviewed publications and more than 10 book chapters and is a frequent speaker at conferences around the world.

Education & Training

  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoFELLOWSHIP
  • PinnacleHealth System - PolyclinicRESIDENCY
  • University of Medicine and Pharmacy ‘Gr T Popa” Iasi
    University of Medicine and Pharmacy ‘Gr T Popa” Iasi MEDICAL_SCHOOL

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2020 - 2020
  • CA State Medical License
    CA State Medical License 2020 - 2022
  • TX State Medical License
    TX State Medical License 2008 - 2020
  • IL State Medical License
    IL State Medical License 2004 - 2011
  • PA State Medical License
    PA State Medical License 2001 - 2004

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
    Stefan O. Ciurea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
    Stefan O. Ciurea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
    Stefan O. Ciurea, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Initial results of two phase I trials delivering mbIL-21 ex vivo expanded haploidentical NK cells after fludarabine/cytarabine for patients with relapsed/refractory my... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles
    CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and NanoparticlesOctober 02, 2018
  • CytoSen Therapeutics Receives FDA’s Favorable Response to Pre-IND Meeting Package for Phase 2 Study in AML
    CytoSen Therapeutics Receives FDA’s Favorable Response to Pre-IND Meeting Package for Phase 2 Study in AMLSeptember 27, 2018

Hospital Affiliations